Showing 21 - 30 of 380
Persistent link: https://www.econbiz.de/10009185333
Persistent link: https://www.econbiz.de/10008406320
In the approaching era of genomic medicine, the underrepresentation of minority populations in human genetics and genomics research has raised growing concerns regarding the distributive justice in the translation of biomedical innovations into human health across populations. Quantitative...
Persistent link: https://www.econbiz.de/10014081996
The government’s anti-COVID efforts in the United States have been seen to reduce unnecessary social mobility, curb the spread of the virus, and lower COVID-related mortality; however, these impacts vary by state. In this paper, we aim to explain the heterogeneity in policy efficacy from an...
Persistent link: https://www.econbiz.de/10014084732
The underrepresentation of minority populations in human genomics research has raised growing concerns regarding distributive justice in translating biomedical innovations into human health across populations. We assess how public funding policy helps address the missing diversity in the context...
Persistent link: https://www.econbiz.de/10014347108
Persistent link: https://www.econbiz.de/10013161602
Persistent link: https://www.econbiz.de/10012224367
We use a rigorous three-stage many-analysts design to assess how different researcher decisions—specifically data cleaning, research design, and the interpretation of a policy question—affect the variation in estimated treatment effects. A total of 146 research teams each completed the same...
Persistent link: https://www.econbiz.de/10015339047
We use a rigorous three-stage many-analysts design to assess how different researcher decisions-specifically data cleaning, research design, and the interpretation of a policy question-affect the variation in estimated treatment effects. A total of 146 research teams each completed the same...
Persistent link: https://www.econbiz.de/10015271879
Persistent link: https://www.econbiz.de/10015182923